Aptamer Group (LON:APTA) Trading 11.2% Higher – Here’s What Happened

Aptamer Group plc (LON:APTA) shares were up 11.2% on Wednesday . The company traded as high as GBX 0.95 and last traded at GBX 0.95. Approximately 16,977,900 shares traded hands during trading, a decline of 0% from the average daily volume of 17,040,719 shares. The stock had previously closed at GBX 0.85.

Aptamer Group Price Performance

The company’s 50-day simple moving average is GBX 0.91 and its 200-day simple moving average is GBX 0.62. The stock has a market capitalization of £28.32 million, a P/E ratio of -7.50 and a beta of -0.52.

Aptamer Group (LON:APTA) last announced its quarterly earnings data on Tuesday, October 14th. The company reported GBX 0.14 EPS for the quarter. Aptamer Group had a negative net margin of 343.95% and a negative return on equity of 205.63%.

Insider Transactions at Aptamer Group

In other Aptamer Group news, insider Adam Hargreaves acquired 5,000,000 shares of the business’s stock in a transaction dated Monday, September 8th. The stock was bought at an average cost of GBX 1 per share, with a total value of £50,000. 8.76% of the stock is owned by corporate insiders.

Aptamer Group Company Profile

Aptamer Group is a leading provider of aptamer selection services and developer of aptamer-based reagents for use in research, bioprocessing, diagnostic, and therapeutic applications. Headquartered in York, UK, the Company partners globally to deliver aptamer-based solutions that drive discovery and development across the life sciences.

Aptamer Group has developed the proprietary Optimer® platform technology that drives three distinct businesses: Aptamer Solutions, Aptamer Diagnostics and Aptamer Therapeutics.